Immunohistochemical comparative analysis of transforming growth factor α, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates

Cytokine

Volumn 11, Issue 9, 1999, Pages 722-727

  De Miguel, Maria P ^a   Royuela, Mar ^a   Bethencourt, Fermin R ^a   Ruiz, Antonio ^a   Fraile, Benito ^a   Paniagua, Ricardo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Benign prostatic hyperplasia; Epidermal growth factor (EGF); Human prostate; Prostatic cancer; Transforming growths factor (TGF )

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; AUTOCRINE EFFECT; BASAL CELL; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROSTATE TUMOR; SECRETORY CELL; STROMA CELL;

EID: 0032840643     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0443     Document Type: Article

References (35)

1. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem. 237:(1962);1555-1562.
2. Gregory H. In vivo aspects of urogastrone-epidermal growth factor. J Cell Sci. Suppl. 3:(1985);11-17.
3. Cohen S, Carpenter G. Human epidermal growth factor: isolation of chemical and biological properties. Proc Natl Acad Sci U S A. 72:(1975);1317-1321.
4. Carpenter G, Wahl M. The epidermal growth factor family. Sporrn MB, Roberts AB. Peptide growth factors and their receptors. (1990);69-171 Springer, Heidelberg.
5. Marquandt H, Hunkapiller MW, Hood LE, Twardzik DK, De Larco JR, Stephenson JR, Todaro GJ. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci U S A. 80:(1983);4684-4688.
6. Derynck R. Transforming growth factor-α: structure and biological activities. J Cell Biochem. 32:(1986);203-204.
7. Story M. Polypeptide modulators of prostatic growth and development. Cancer Surveys. 11:(1991);123-146.
8. Hunter T. The epidermal growth factor receptor gene and its product. Nature. 311:(1984);414-416.
9. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem. 56:(1987);881-914.
10. Reynolds FH Jr, Todaro GJ, Fryling C, Stephenson JR. Human transforming growth factors induces tyrosine phosphorylation of EGF receptors. Nature. 292:(1981);259-262.
11. Gregory H, Willshire IR, Kavanagh JP, Blacklock NJ, Clowdury S, Richards RC. Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy. Clin Sci. 70:(1986);359-363.
12. Taylor TB, Ramsdell JS. Transforming growth factor-α and its receptor are expressed in the epithelium of the rat prostate gland. Endocrinol. 133:(1993);1306-1311.
13. Fowler JE Jr, Lau JLT, Grosh L, Mills SE, Mounzer A. Epidermal growth factor and prostatic carcinoma: an immunohistochemical study. J Urol. 139:(1988);857-861.
14. Damjanov I, Mildner B, Knowles BB. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest. 55:(1986);588-592.
15. Maddy SQ, Chisholm GD, Hawkins RA, Habib FK. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. J Endocrinol. 113:(1987);147-153.
16. Eaton CL, Davies P, Phillips MEA. Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem. 30:(1988);341-345.
17. Harper ME, Goddard L, Glynne-Jones E, Wilson DW, Price-Thomas M, Peeling WB, Griffiths K. An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors. Prostate. 23:(1993);9-23.
18. Wilding G, Valverius E, Knabbe C, Gelmann E. Role of transforming growth factor-α in human prostate cancer cell growth. Prostate. 15:(1989);1-12.
19. Habib FK. Peptide growth factors: a new frontier in prostate cancer. Prog Clin Biol Res. 357:(1990);107-115.
20. Shaikh N, Lai L, McLoughlin J, Clark D, Williams G. Quantitative analysis of epidermal growth factor in human benign prostatic hyperplasia and prostatic carcinoma and its prognostic significance. Anticancer Res. 10:(1990);873-874.
21. Ibrahim FK, Kerns B-JM, MacDonald JA, Ibrahim SN, Kinney RB, Humphrey PA, Robertson CN. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J Urol. 149:(1993);170-173.
22. Maygarden SJ, Strom S, Ware JL. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med. 116:(1992);269-273.
23. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE, Macoska JA. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant and malignant prostate tissue. Prostate. 25:(1994);199-205.
24. Davidson NE, Gelmann EP, Lippman ME, Dickson RB. Epidermal growths factor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol. 1:(1987);216-223.
25. MacDonald A, Habib FK. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer. 65:(1992);177-182.
26. Morris GL, Dodd JG. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol. 143:(1990);1272-1274.
27. Davis P, Eaton CL. Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate. 14:(1989);123-132.
28. Maddy SQ, Chisholm GD, Bussuttil A, Habib FK. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour. Br J Cancer. 60:(1989);41-44.
29. Cohen S, Simak R, Fair WR, Mlamed J, Scher HI, Cordon-Cardo C. Expression of transforming growth factor α and the epidermal growth factor receptor in human prostate tissues. J Urol. 152:(1994);2120-2124.
30. Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J, Cordon-Cardo C. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor-α in the progression of prostatic neoplasms. Clin Cancer Res. 1:(1995);545-550.
31. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC. Overexpression of TGF-α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 61:(1990);1121-1136.
32. Steiner MS. Role of peptide growth factors in the prostate. A review. Urology. 42:(1993);99-110.
33. DiMarco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP. Autocrine interaction between TGF alpha and the EGF-receptor: Quantitative requirements for the induction of the malignant phenotype. Oncogene. 4:(1989);831-838.
34. Davies DE, Chamberlim SG. Targeting the epidermal growths factor receptor for therapy of carcinomas. Biochem Pharmacol. 51:(1996);1101-1110.
35. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 72:(1976);248-254.